文献速递心脑血管急症重症综合管理与镇静镇痛

心肌梗死后限制性 versus 宽松输血策略:MINT随机临床试验的事后分析

Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2026-07-01
一句话结论在合并贫血的心肌梗死患者中,宽松输血策略与30天死亡或心梗风险降低相关,其获益可能超过心衰风险增加。

该研究为MINT随机临床试验的事后贝叶斯分析,纳入3504例合并贫血的心肌梗死成人患者,随机接受限制性(血红蛋白<7-8 g/dL时输血)或宽松(维持血红蛋白>10 g/dL)输血策略。结果显示,宽松策略与30天死亡或心梗风险降低1.4%至2.4%相关(95%可信区间随先验信念变化),而心衰风险增加0.2%至0.6%(95%可信区间均包含0)。结论提示,宽松输血策略可能合理,但需结合患者价值观和临床风险评估。

要点

  • 在合并贫血的心肌梗死患者中,宽松输血策略(维持Hb>10 g/dL)与30天死亡或心梗风险降低相关,绝对风险降低1.4%至2.4%。
  • 宽松策略与心衰风险增加0.2%至0.6%相关,但95%可信区间均包含0,且概率分析显示心衰风险增加的可能性为60.6%至80.0%。
  • 宽松策略使30天死亡或心梗风险降低的概率为89.1%至98.8%,每治疗100例至少减少1例死亡或心梗的概率为62.7%至90.4%。
  • 每治疗100例至少增加1例心衰事件的概率仅为13.3%至29.3%,提示心衰风险增加的可能性较低。
  • 结论支持在合并贫血的心肌梗死患者中,根据患者价值观和临床风险评估,宽松输血策略可能合理。

适用人群与场景

  • 纳入标准:成人(平均年龄72.1岁,SD 11.6),因心肌梗死合并贫血住院的患者,来自6个国家144个中心, recruitment时间2017年4月26日至2023年4月14日。
  • 排除标准:原文未提及。
  • 适用场景:急诊/ICU住院期间的心肌梗死合并贫血患者的输血决策。

诊断标准与关键阈值

  • 限制性输血策略:血红蛋白<7至8 g/dL时输血。
  • 宽松输血策略:维持血红蛋白>10 g/dL。
  • 诊断标准:心肌梗死和贫血的定义原文未提及。

处置流程与药物剂量

  • 第一步:评估心肌梗死合并贫血患者,考虑输血策略。
  • 第二步:限制性策略为血红蛋白<7至8 g/dL时输血;宽松策略为维持血红蛋白>10 g/dL。
  • 第三步:根据患者价值观和临床风险评估,宽松输血策略可能合理。
  • 药物剂量:原文未提及具体输血剂量、途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:MINT随机临床试验的事后贝叶斯分析;样本量3504例,来自6个国家144个中心;人群为心肌梗死合并贫血的成人住院患者。
  • 干预与对照:限制性输血策略(Hb<7-8 g/dL时输血) vs 宽松输血策略(维持Hb>10 g/dL)。
  • 主要终点:30天死亡或心梗;宽松策略 vs 限制性策略的风险降低1.4%(95%可信区间-0.8%至3.5%)至2.4%(95%可信区间0.3%至4.6%),取决于先验信念。
  • 关键次要终点:心衰;宽松策略 vs 限制性策略的风险增加0.2%(95%可信区间-1.6%至1.2%)至0.6%(95%可信区间-2.0%至0.8%),取决于先验信念。
  • 概率分析:宽松策略降低30天死亡或心梗风险的概率为89.1%至98.8%;增加心衰风险的概率为60.6%至80.0%。

证据类型、等级与局限

  • 证据类型:随机临床试验(MINT)的事后贝叶斯分析。
  • 证据等级或推荐强度:原文未提及。
  • 局限:事后分析;原文未提及其他局限。

对床旁实践的改变

  • 对于心肌梗死合并贫血的住院患者,宽松输血策略(维持Hb>10 g/dL)可能降低30天死亡或心梗风险,但需结合患者价值观和临床风险评估。
  • 不适用人群:原文未提及。
  • 常见陷阱:原文未提及。

指南或共识出处

  • 指南或共识名称:原文未提及具体指南名称,仅提及「与指南推荐一致」。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: The decision to transfuse a patient with myocardial infarction (MI) and anemia at a higher vs lower hemoglobin threshold must consider the potential benefit of reduced risk of 30-day death or MI and the potential risk of heart failure.

OBJECTIVES: To estimate bayesian posterior risk differences and posterior probabilities that a liberal vs restrictive transfusion strategy is associated with reduced risk of 30-day death or MI and whether the probabilities exceed predefined thresholds.

DESIGN, SETTING, AND PARTICIPANTS: The Myocardial Ischemia and Transfusion (MINT) trial recruited adults from April 26, 2017, to April 14, 2023, who were hospitalized with MI and anemia at 144 sites in 6 countries. Statistical analysis was performed from July 31, 2024, to February 18, 2026.

INTERVENTION: The MINT trial randomized participants to a restrictive (transfuse if hemoglobin is <7 to 8 g/dL) or liberal (maintain hemoglobin at >10 g/dL) transfusion strategy.

MAIN OUTCOMES AND MEASURES: Bayesian posterior risk differences were estimated for 30-day death or MI and for heart failure using 3 prior beliefs regarding the treatment strategies: noninformative, liberal strategy superiority, or restrictive strategy superiority.

RESULTS: The mean (SD) age of the 3504 participants was 72.1 (11.6) years and 1911 (54.5%) were men. Compared with the restrictive strategy, the risk of 30-day death or MI with the liberal strategy was 1.4% (95% credible interval, -0.8% to 3.5%) to 2.4% (95% credible interval, 0.3%-4.6%) lower, depending on prior beliefs. The probability that the liberal strategy was associated with a lower risk of 30-day death or MI ranged from 89.1% to 98.8%, and the probability that a liberal strategy was associated with at least 1 less death or MI per 100 treated was between 62.7% and 90.4%. Conversely, the risk of heart failure with the liberal strategy was 0.2% (95% credible interval, -1.6% to 1.2%) to 0.6% (95% credible interval, -2.0% to 0.8%) higher compared with the restrictive strategy, depending on prior beliefs. The probability that the liberal strategy was associated with a higher risk of heart failure ranged from 60.6% to 80.0%, and the probability that a liberal strategy was associated with at least 1 more heart failure event per 100 treated was between 13.3% and 29.3%.

CONCLUSIONS AND RELEVANCE: This post hoc analysis of a randomized clinical trial of patients with MI and anemia suggests that a liberal transfusion strategy was associated with a lower risk of 30-day death or MI, outweighing the increased risk of heart failure. Consistent with guideline recommendations and according to patients' values and clinician risk assessment, a liberal transfusion strategy may be reasonable.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02981407.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Bertolet M, Carrier FM, Glynn S, et al. Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized Clinical Trial. JAMA Netw Open. 2026. PMID: 42507445. doi:10.1001/jamanetworkopen.2026.24991

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。